Sessions are scheduled in local time (CEST)

Displaying One Session

View
Frankfurt Hall Industry Satellite Symposium

Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

Date
Thu, 11.05.2023
Time
11:30 - 12:30
Room
Frankfurt Hall
Chairs
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

Welcome and introductions (ID 945)

Lecture Time
11:30 - 11:35
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

First-line treatment in HR+/HER2- ABC: Patient cases (ID 946)

Lecture Time
11:35 - 12:00
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

Sequencing following progression after first-line CDK4/6i: Patient cases (ID 947)

Lecture Time
12:00 - 12:20
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Michelino De Laurentiis (Napoli, Italy)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

Closing and key takeaways (ID 948)

Lecture Time
12:20 - 12:25
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)

Live Q&A (ID 949)

Lecture Time
12:25 - 12:30
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 23)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30